Stockscreener 앱 받기
25.23
0.08%
-0.02
전일 마감가:
$25.25
열려 있는:
$25.23
하루 거래량:
1.35M
Relative Volume:
0.52
시가총액:
$11.21B
수익:
$2.27B
순이익/손실:
$1.15B
주가수익비율:
224.27
EPS:
0.1125
순현금흐름:
$2.80B
1주 성능:
+0.44%
1개월 성능:
-4.54%
6개월 성능:
-6.93%
1년 성능:
-8.42%
1일 변동 폭
$25.02
$25.35
1주일 범위
$24.05
$25.35
52주 변동 폭
$24.05
$31.66
로열티 파마 Stock (RPRX) Company Profile
명칭
Royalty Pharma Plc
전화
(212) 883-0200
주소
110 EAST 59TH STREET, NEW YORK, NY
RPRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
25.23 | 11.21B | 2.27B | 1.15B | 2.80B | 2.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.18 | 105.12B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
714.47 | 78.51B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
629.99 | 37.67B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
243.25 | 31.37B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
114.13 | 27.36B | 3.30B | -501.07M | 1.03B | -2.1146 |
로열티 파마 Stock (RPRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-06-14 | 재개 | UBS | Buy |
| 2022-05-13 | 개시 | Scotiabank | Sector Outperform |
| 2022-04-27 | 개시 | Goldman | Buy |
| 2022-04-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-04-06 | 재개 | Morgan Stanley | Overweight |
| 2021-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-07-30 | 개시 | Tigress Financial | Buy |
| 2020-11-09 | 업그레이드 | UBS | Neutral → Buy |
| 2020-07-14 | 개시 | Evercore ISI | In-line |
| 2020-07-13 | 개시 | BofA Securities | Buy |
| 2020-07-13 | 개시 | Citigroup | Neutral |
| 2020-07-13 | 개시 | Cowen | Outperform |
| 2020-07-13 | 개시 | Goldman | Neutral |
| 2020-07-13 | 개시 | JP Morgan | Neutral |
| 2020-07-13 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-07-13 | 개시 | SunTrust | Buy |
| 2020-07-13 | 개시 | UBS | Neutral |
모두보기
로열티 파마 주식(RPRX)의 최신 뉴스
Royalty Pharma (NASDAQ:RPRX) Rating Increased to Strong-Buy at TD Cowen - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) is favoured by institutional owners who hold 72% of the company - Yahoo Finance
Jim Cramer Calls Royalty Pharma (RPRX) ‘Disappointing’ But Recommends Holding – ‘I Want You To Stick With It’ - Insider Monkey
Royalty Pharma (NASDAQ:RPRX) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
Wellington Management Group LLP Sells 39,598 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Franklin Resources Inc. Grows Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Barclays PLC Raises Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Reaches New 12-Month LowWhat's Next? - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Stake Boosted by Geode Capital Management LLC - MarketBeat
Synovus Financial Corp Sells 118,379 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Relative Strength Alert For Royalty Pharma - Nasdaq
3 High-Yield Dividend Stocks to Buy in 2025 and Hold for a Decade or Longer - The Motley Fool
Royalty Pharma stock hits 52-week low at $25.1 amid market shifts - Investing.com Australia
Royalty Pharma stock hits 52-week low at $25.1 amid market shifts By Investing.com - Investing.com South Africa
State Street Corp Grows Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Executive Wealth Management LLC Sells 22,839 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Kovitz Investment Group Partners LLC Sells 50,665 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Point72 Asset Management L.P. Takes $14.90 Million Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
The Manufacturers Life Insurance Company Has $4.30 Million Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Two Sigma Advisers LP Increases Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
(RPRX) Investment Analysis - Stock Traders Daily
Point72 DIFC Ltd Purchases New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Is Royalty Pharma (RPRX) the Best All-Time Low Stock to Buy Right Now? - Insider Monkey
2 Exceptional Dividend Stocks Near 52-Week Lows You Could Regret Not Buying on the Dips - The Motley Fool
ArrowMark Colorado Holdings LLC Invests $2.03 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
PDT Partners LLC Sells 20,502 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Position Decreased by Glenmede Trust Co. NA - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Bank of Montreal Can - MarketBeat
45,965 Shares in Royalty Pharma plc (NASDAQ:RPRX) Purchased by D.A. Davidson & CO. - MarketBeat
Eventide Asset Management LLC Buys 22,993 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
How Royalty Pharma, Open Text And VICI Properties Can Put Cash In Your Pocket - Yahoo Finance
Charles Schwab Investment Management Inc. Has $84.92 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Citigroup Inc. Has $14.95 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma to Present at Upcoming Investor Conferences - The Manila Times
Royalty Pharma to Present at Two Major Healthcare Investor Conferences in December | RPRX Stock News - StockTitan
Why Royalty Pharma (RPRX) is the Cheapest Stock to Buy on Robinhood? - MSN
Dai ichi Life Insurance Company Ltd Boosts Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Qsemble Capital Management LP Takes Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
10 Cheapest Stocks to Buy On Robinhood - Insider Monkey
(RPRX) Trading Advice - Stock Traders Daily
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Raises Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Thrivent Financial for Lutherans Purchases 168,905 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Overbrook Management Corp Sells 59,504 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Victory Capital Management Inc. - MarketBeat
RPRXRoyalty Pharma plc Latest Stock News & Market Updates - StockTitan
Amalgamated Bank Sells 48,057 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy + - Seeking Alpha
로열티 파마 (RPRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
로열티 파마 주식 (RPRX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RIGGS RORY B | Director |
Jan 03 '24 |
Sale |
27.79 |
199,098 |
5,532,276 |
55,801 |
| RIGGS RORY B | Director |
Jan 04 '24 |
Sale |
27.55 |
35,702 |
983,504 |
20,099 |
| Avara Management Ltd | 10% Owner |
Dec 29 '23 |
Sale |
28.04 |
65,803 |
1,845,406 |
2,477,520 |
| Avara Management Ltd | 10% Owner |
Dec 28 '23 |
Sale |
28.20 |
209,863 |
5,918,934 |
2,543,323 |
| Avara Management Ltd | 10% Owner |
Dec 27 '23 |
Sale |
28.01 |
41,729 |
1,168,754 |
2,753,186 |
0.10%
0.76%
자본화:
|
볼륨(24시간):